Harry Haber

2.8k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

Harry Haber is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Harry Haber has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Surgery. Recurrent topics in Harry Haber's work include Blood Pressure and Hypertension Studies (9 papers), Cardiac Imaging and Diagnostics (5 papers) and Diabetes Treatment and Management (5 papers). Harry Haber is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Cardiac Imaging and Diagnostics (5 papers) and Diabetes Treatment and Management (5 papers). Harry Haber collaborates with scholars based in United States, Canada and Switzerland. Harry Haber's co-authors include Blair J. O’Neill, Todd J. Anderson, François Charbonneau, Bertram Pitt, Eleanor Elstein, Andrew C. G. Uprichard, Harald Mudra, Carl J. Pepine, Thomas J. Wargovich and G.B. John Mancini and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Harry Haber

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

1996 837 citations G.B. John Mancini, Blair J. O’Neill et al. profile →

Peers

Harry Haber

CCM

EDM

SURGE

PHYSI

Roberto Marchioli Italy

Yoh Miyashita Japan

Eak Kyun Shin South Korea

Pia Lundman Sweden

Andrei Breazna United States

Athanasios A. Papageorgiou Greece

Emily K Marino United States

Ralph T. Doyle United States

Joel Neutel United States

Steven Ketchum United States

Roberto Marchioli Italy

Harry Haber

926 ×0.7

CCM

560 ×0.8

EDM

652 ×1.0

SURGE

402 ×1.1

PHYSI

370 ×1.6

Citations per year, relative to Harry Haber Harry Haber (= 1×) peers Roberto Marchioli

Countries citing papers authored by Harry Haber

Since Specialization

Citations

This map shows the geographic impact of Harry Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Haber more than expected).

Fields of papers citing papers by Harry Haber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Haber. The network helps show where Harry Haber may publish in the future.

Co-authorship network of co-authors of Harry Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Haber. A scholar is included among the top collaborators of Harry Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Haber. Harry Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laurent, Didier, Lorcan Walsh, Amir Muaremi, et al.. (2020). Relationship between tendon structure, stiffness, gait patterns and patient reported outcomes during the early stages of recovery after an Achilles tendon rupture. Scientific Reports. 10(1). 20757–20757. 27 indexed citations

Laurent, Didier, Lorcan Walsh, Amir Muaremi, et al.. (2019). Relationship between recovery of tendon biomechanics, gait and patient function after Achilles tendon rupture. Osteoarthritis and Cartilage. 27. S473–S473.

Kovacs, Richard J., Harry Haber, R. Alan Wright, et al.. (2013). Evaluation of the Effects of Duloxetine and Escitalopram on 24-Hour Heart Rate Variability. Journal of Clinical Psychopharmacology. 33(2). 236–239. 6 indexed citations

Eisenhofer, Graeme, Michael J. Owens, Harry Haber, et al.. (2013). Effects of Duloxetine on Norepinephrine and Serotonin Transporter Activity in Healthy Subjects. Journal of Clinical Psychopharmacology. 34(1). 9–16. 13 indexed citations

Keller, Jutta, Michael Trautmann, Harry Haber, et al.. (2012). Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects. Regulatory Peptides. 179(1-3). 77–83. 52 indexed citations

Onishi, Yukiko, Hiroyuki Koshiyama, Takeshi Imaoka, et al.. (2012). Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 4(2). 182–189. 11 indexed citations

Norwood, Paul, Joanne Liutkus, Harry Haber, et al.. (2012). Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years. Clinical Therapeutics. 34(10). 2082–2090. 22 indexed citations

Onishi, Yukiko, Chul Woo Ahn, Pankaj Kumar Agarwal, et al.. (2012). Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 4(1). 53–61. 67 indexed citations

Beasley, Charles M., Charles Benson, S. Stanley Young, et al.. (2011). Systematic Decrements in QTc between the First and Second Day of Contiguous Daily ECG Recordings under Controlled Conditions. Pacing and Clinical Electrophysiology. 34(9). 1116–1127.

10.

Pepine, Carl J., Jean‐Lucien Rouleau, Anique Ducharme, et al.. (2003). Effects of angiotensin-converting enzyme inhibition on transient ischemia. Journal of the American College of Cardiology. 42(12). 2049–2059. 26 indexed citations

11.

Pitt, Bertram, Blair J. O’Neill, Robert Feldman, et al.. (2001). The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. The American Journal of Cardiology. 87(9). 1058–1063. 152 indexed citations

12.

Anderson, Todd J., Eleanor Elstein, Harry Haber, & François Charbonneau. (2000). Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Journal of the American College of Cardiology. 35(1). 60–66. 296 indexed citations

13.

Mancini, G.B. John, et al.. (1999). Influence of Smoking Status on Angiotensin-Converting Enzyme Inhibition–Related Improvement in Coronary Endothelial Function. Cardiovascular Drugs and Therapy. 13(3). 201–209. 11 indexed citations

14.

Pepine, Carl J., et al.. (1998). Influence of smoking status on progression of endothelial dysfunction. Clinical Cardiology. 21(5). 331–334. 26 indexed citations

15.

Davidson, Michael H., et al.. (1998). Gemfibrozil Treatment in Patients with Elevated Lipoprotein A. Clinical Drug Investigation. 16(1). 1–7. 3 indexed citations

16.

Anderson, Todd J., et al.. (1998). A Comparative study of four anti-hypertensive agents on endothelial function in patients with coronary disease. Journal of the American College of Cardiology. 31. 327–327. 11 indexed citations

17.

Davidson, Michael H., Stuart Weiss, Sherwyn Schwartz, et al.. (1997). Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals. The American Journal of Cardiology. 80(3). 347–348. 18 indexed citations

18.

Syvänne, Mikko, Marja‐Riitta Taskinen, Markku S. Nieminen, et al.. (1997). A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. Controlled Clinical Trials. 18(1). 93–119. 20 indexed citations

19.

Wargovich, Thomas J., Blair J. O’Neill, G.B.John Mancini, et al.. (1997). Effects of Quinapril on Coronary Blood Flow in Coronary Artery Disease Patients With Endothelial Dysfunction. The American Journal of Cardiology. 80(12). 1594–1597. 44 indexed citations

20.

Chan, Raymond C., Godtfred Holmvang, Robert E. Dinsmore, et al.. (1996). Baseline clinical and angiographic data in the quinapril ischemic event (QUIET) Trial. The American Journal of Cardiology. 78(9). 1011–1016. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact